Choledocholithiasis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: CBBA924DDEABEN
Market Monitor Global

Abstracts

Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder.

This report contains market size and forecasts of Choledocholithiasis Treatment in Global, including the following market information:

Global Choledocholithiasis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Choledocholithiasis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Choledocholithiasis Treatment include AstraZeneca, Novartis, GSK, Pfizer, Abbott, GE, Celgene and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Choledocholithiasis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Choledocholithiasis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Choledocholithiasis Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Treatment
• Surgical Treatment

Global Choledocholithiasis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Choledocholithiasis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialist Clinic
• Others

Global Choledocholithiasis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Choledocholithiasis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Choledocholithiasis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Choledocholithiasis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Novartis
• GSK
• Pfizer
• Abbott
• GE
• Celgene
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Choledocholithiasis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Choledocholithiasis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHOLEDOCHOLITHIASIS TREATMENT OVERALL MARKET SIZE

2.1 Global Choledocholithiasis Treatment Market Size: 2021 VS 2028
2.2 Global Choledocholithiasis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Choledocholithiasis Treatment Players in Global Market
3.2 Top Global Choledocholithiasis Treatment Companies Ranked by Revenue
3.3 Global Choledocholithiasis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Choledocholithiasis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Choledocholithiasis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Choledocholithiasis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Choledocholithiasis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Choledocholithiasis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Choledocholithiasis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Surgical Treatment
4.2 By Type - Global Choledocholithiasis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Choledocholithiasis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Choledocholithiasis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Choledocholithiasis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialist Clinic
  5.1.4 Others
5.2 By Application - Global Choledocholithiasis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Choledocholithiasis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Choledocholithiasis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Choledocholithiasis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Choledocholithiasis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Choledocholithiasis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Choledocholithiasis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Choledocholithiasis Treatment Revenue, 2017-2028
  6.3.2 US Choledocholithiasis Treatment Market Size, 2017-2028
  6.3.3 Canada Choledocholithiasis Treatment Market Size, 2017-2028
  6.3.4 Mexico Choledocholithiasis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Choledocholithiasis Treatment Revenue, 2017-2028
  6.4.2 Germany Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.3 France Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.4 U.K. Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.5 Italy Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.6 Russia Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Choledocholithiasis Treatment Market Size, 2017-2028
  6.4.8 Benelux Choledocholithiasis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Choledocholithiasis Treatment Revenue, 2017-2028
  6.5.2 China Choledocholithiasis Treatment Market Size, 2017-2028
  6.5.3 Japan Choledocholithiasis Treatment Market Size, 2017-2028
  6.5.4 South Korea Choledocholithiasis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Choledocholithiasis Treatment Market Size, 2017-2028
  6.5.6 India Choledocholithiasis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Choledocholithiasis Treatment Revenue, 2017-2028
  6.6.2 Brazil Choledocholithiasis Treatment Market Size, 2017-2028
  6.6.3 Argentina Choledocholithiasis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Choledocholithiasis Treatment Revenue, 2017-2028
  6.7.2 Turkey Choledocholithiasis Treatment Market Size, 2017-2028
  6.7.3 Israel Choledocholithiasis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Choledocholithiasis Treatment Market Size, 2017-2028
  6.7.5 UAE Choledocholithiasis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Choledocholithiasis Treatment Major Product Offerings
  7.1.4 AstraZeneca Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Choledocholithiasis Treatment Major Product Offerings
  7.2.4 Novartis Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Choledocholithiasis Treatment Major Product Offerings
  7.3.4 GSK Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.3.5 GSK Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Choledocholithiasis Treatment Major Product Offerings
  7.4.4 Pfizer Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Choledocholithiasis Treatment Major Product Offerings
  7.5.4 Abbott Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Abbott Key News
7.6 GE
  7.6.1 GE Corporate Summary
  7.6.2 GE Business Overview
  7.6.3 GE Choledocholithiasis Treatment Major Product Offerings
  7.6.4 GE Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.6.5 GE Key News
7.7 Celgene
  7.7.1 Celgene Corporate Summary
  7.7.2 Celgene Business Overview
  7.7.3 Celgene Choledocholithiasis Treatment Major Product Offerings
  7.7.4 Celgene Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Celgene Key News
7.8 Eli Lilly
  7.8.1 Eli Lilly Corporate Summary
  7.8.2 Eli Lilly Business Overview
  7.8.3 Eli Lilly Choledocholithiasis Treatment Major Product Offerings
  7.8.4 Eli Lilly Choledocholithiasis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Choledocholithiasis Treatment Market Opportunities & Trends in Global Market
Table 2. Choledocholithiasis Treatment Market Drivers in Global Market
Table 3. Choledocholithiasis Treatment Market Restraints in Global Market
Table 4. Key Players of Choledocholithiasis Treatment in Global Market
Table 5. Top Choledocholithiasis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Choledocholithiasis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Choledocholithiasis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Choledocholithiasis Treatment Product Type
Table 9. List of Global Tier 1 Choledocholithiasis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Choledocholithiasis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Choledocholithiasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Choledocholithiasis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Choledocholithiasis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Choledocholithiasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Choledocholithiasis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Choledocholithiasis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Choledocholithiasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Choledocholithiasis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Choledocholithiasis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Choledocholithiasis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Choledocholithiasis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Choledocholithiasis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Choledocholithiasis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Choledocholithiasis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Choledocholithiasis Treatment Product Offerings
Table 32. AstraZeneca Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Choledocholithiasis Treatment Product Offerings
Table 35. Novartis Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GSK Corporate Summary
Table 37. GSK Choledocholithiasis Treatment Product Offerings
Table 38. GSK Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Choledocholithiasis Treatment Product Offerings
Table 41. Pfizer Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Choledocholithiasis Treatment Product Offerings
Table 44. Abbott Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GE Corporate Summary
Table 46. GE Choledocholithiasis Treatment Product Offerings
Table 47. GE Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Celgene Corporate Summary
Table 49. Celgene Choledocholithiasis Treatment Product Offerings
Table 50. Celgene Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Choledocholithiasis Treatment Product Offerings
Table 53. Eli Lilly Choledocholithiasis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Choledocholithiasis Treatment Segment by Type in 2021
Figure 2. Choledocholithiasis Treatment Segment by Application in 2021
Figure 3. Global Choledocholithiasis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Choledocholithiasis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Choledocholithiasis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Choledocholithiasis Treatment Revenue in 2021
Figure 8. By Type - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 12. US Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 24. China Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Choledocholithiasis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Choledocholithiasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GSK Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GE Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celgene Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Choledocholithiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)